Abiopharma

🔍 CARUSO JAMES V (Director)

Company: Cellectar Biosciences, Inc. (CLRB)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 8,680 shares of Common Stock at $2.88 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 20,318.00 | transaction_form_type: 4
• Acquired 26,040 shares of Warrants at $2.88 per share (Derivative)
  Date: 2026-05-07 | Code: P | Exercise: 2026-05-07 | equity_swap_involved: 0 | shares_owned_after: 36,076.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Expiration dates are as follows: Tranche A shall have a one-year term from the date of stockholder approval; Tranche B shall have a two-year term from the date of stockholder approval; Tranche C shall have a five-year term from the date of stockholder approval.